CIDRAP newsletters options
The National Institute of Allergy and Infectious Diseases (NIAID) yesterday announced that it is enrolling participants for two phase 3 trials of two different monoclonal antibody treatments for COVID-19.
CARB-X announced today that it is awarding $2.91 million to German drug developer Evotec SE to develop a new class of antibiotics to treat infections caused by multidrug-resistant bacteria.
As cases surge in intense transmission countries, illness levels are rising in countries that curbed the spread, including many in Europe.
In a prospective study, the test accurately predicted patients who could be cured with the oral antibiotic.
Meanwhile, experts warn that a window of opportunity to control the virus is short, ahead of a likely new COVID-19 surge in the fall.
Two more Ebola cases were confirmed in the Democratic Republic of Congo (DRC) outbreak in Equateur province, bringing the total to 79, the World Health Organization (WHO) African regional office said today in a Twitter update.
No new deaths were reported, keeping the fatality count at 33.
In other developments, the CDC and the State Department lifted international travel bans and lawmakers remained at odds over the latest COVID-19 relief package.
Cases in Africa passed the 1 million mark, as more countries in Europe reported notable spikes in cases.
A web-based survey of physicians in 23 countries indicates widespread broad-spectrum antibiotic use in COVID-19 patients, an international team of researchers reported today in the Journal of Antimicrobial Chemotherapy.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Patients with confirmed asymptomatic COVID-19 infections shed virus at similar levels to those who are experiencing symptoms, underscoring the importance of public health actions to control the spread of the virus, researchers from South Korea reported yesterday in JAMA Internal Medicine.
"All efforts and attacks should be directed against the virus," the authors of a commentary write.
Also, FDA Commissioner Stephen Hahn promises safety and efficacy as vaccines are developed.
The finding suggests that routine susceptibility testing of meningococcal isolates could help guide treatment and prevention.
Moods have deteriorated among US hourly service workers and their children since COVID-19 began.
As the world nears the 19 million COVID-19-case milestone, stubbornly brisk activity continues.
A small single-center case series published today in Pediatrics describes only mild illness in seven hospitalized infants in New York City with COVID-19 and fever, with none requiring supplemental oxygen, mechanical ventilation, or intensive care.
Many states don't offer the policies and flexibility voters will need to avoid COVID-19.
A WHO surge team deployment comes after discussions with South Africa's health ministry.
Three Republican and 4 Democratic governors announce an interstate compact for rapid tests.
